M&A Deal Summary

Syneos Health Acquires Synteract

On October 29, 2020, Syneos Health acquired life science company Synteract from Amulet Capital Partners

Acquisition Highlights
  • This is Syneos Health’s 3rd transaction in the Life Science sector.
  • This is Syneos Health’s 3rd transaction in the United States.
  • This is Syneos Health’s 1st transaction in California.

M&A Deal Summary

Date 2020-10-29
Target Synteract
Sector Life Science
Buyer(s) Syneos Health
Sellers(s) Amulet Capital Partners
Deal Type Add-on Acquisition
Advisor(s) Jefferies (Financial)
Skadden, Arps, Slate, Meagher & Flom (Legal)

Target

Synteract

Carlsbad, California, United States
Synteract, Inc. is an operator of a full-service international contract research organization (CRO) focused on Phase I‐IV clinical trials for emerging to mid-sized biopharma clients in the U.S., Europe, and Asia. Synteract was founded in 1995 and is based in Carlsbad, California.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Syneos Health

Morrisville, North Carolina, United States

Category Company
Founded 2010
Sector Life Science
Revenue 4.4B USD (2020)
DESCRIPTION

Syneos Health is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. Syneos Health translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Syneos Health was founded in 2010 and is based in Morrisville, North Carolina.


DEAL STATS #
Overall 4 of 7
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 2 of 5
State (California) 1 of 2
Country (United States) 3 of 5
Year (2020) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-20 Kinapse

London, United Kingdom

Kinapse Ltd. is a provider of outsourced and consultancy services to the global life sciences industry with a particular focus on the areas of regulatory and compliance services. Kinapse is based in London, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-18 Illingworth Research Group

Larkwood Way, United Kingdom

Illingworth Research Group is a provider of clinical research home health services, providing highly trained, qualified and experienced research nurses to the biopharmaceutical and medical device industries. Illingworth Research Group is based in Larkwood Way, United Kingdom.

Buy -

Seller(S) 1

DESCRIPTION

Amulet Capital Partners is a private investment firm focused on middle-market investments in the healthcare sector. Amulet looks to commit $25 to $150 million per transaction to a support a variety of transaction situations including, buyouts, corporate divestitures, growth capital financings, and special situations. Amulet Capital was established in 2013 and is headquartered in Greenwich, Connecticut.


DEAL STATS #
Overall 2 of 3
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 2 of 2
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-21 US Fertility

Rockville, Maryland, United States

US Fertility is a physician practice management company providing business support services of top-tier fertility programs across the United States. The affiliated clinical practices represent the leading fertility programs in their respective markets, united under a shared mission to drive innovation and leverage best practices to enhance both the patient experience and treatment outcomes. US Fertility was founded in 2020 and is based in Rockville, Maryland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-21 SSI Strategy

Parsippany, New Jersey, United States

SSI Strategy is a boutique management-consulting firm that has designed a unique model to support scientific functions within Life Science companies. SSI Strategy is based in Parsippany, New Jersey.

Buy -